Cystic and cavitating lung lesions as a presenting finding of metastatic prostate cancer
Authors: Michael A Cilento and Christopher M Hocking
Published online: 7 June 2021
A 56-year-old man presented with cough, dyspnoea and urinary symptoms

A 56‐year‐old man presented with cough, dyspnoea and urinary symptoms. He was prescribed antibiotics and, when the symptoms did not improve, a computed tomography (CT) scan was ordered. The CT scan showed innumerable cavitating, cystic and solid lesions throughout both lungs, predominantly affecting the upper zones (Figure, A and B). Differential diagnosis for multiple cavitating and cystic lung lesions includes malignant, infective, vascular and inflammatory causes. Pulmonary metastases can occur secondary to a variety of primary cancers; cavitation may be suggestive of squamous cell carcinomas or less commonly sarcomas or adenocarcinomas.1
Bone scan showed metastatic disease. Prostate‐specific antigen (PSA) blood test result was elevated to 199 µg/L (reference interval, 0.3–4.0 µg/L). Core biopsies of a lung lesion revealed metastatic prostate adenocarcinoma.
The patient started androgen deprivation therapy and received standard of care treatment with six cycles of docetaxel chemotherapy,2 with a reduction in PSA to 0.05 µg/L and a marked improvement in the multiple pulmonary lesions on CT scan (Figure, C and D).
Competing interests
No relevant disclosures.
References
- Seo JB, Im JG, Goo JM, et al. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics 2001; 21: 403–417.
- Kyriakopoulos CE, Chen YH, Carducci MA, et al. Chemohormonal therapy in metastatic hormone‐sensitive prostate cancer: long‐term survival analysis of the randomized phase III E3805 CHAARTED trial. J Clin Oncol 2018; 36: 1080–1087.
Challenges and Opportunities for Strong and Dynamic Foundations in the Australian Cancer Plan
Ashley M. Hopkins, Andrew Rowland, Natansh D. Modi, Ceara Rickard, Mark Haseloff, Norma B. Bulamu, Imogen Ramsey, Niranjan Bidargaddi, Ganessan Kichenadasse, Michael J. Sorich, Kalinda E. Griffiths, Aideen McInerney-Leo, David M. Roder, Raymond J. Chan
Opportunities and Challenges to Achieving the Australian Cancer Plan Goal of World Class Health Systems for Optimal Cancer Care
Carolyn Ee, Ria Joseph, Elise Button, Stacey George, Makala Castelli, David Currow, Prue Cormie, Olivia Farrer, Michael Jefford, Nicolas H. Hart, Chad Y. Han, Deidre D. Morgan, Michael P. Osborn, Candice Oster, Joel Rhee, Anna Ugalde, Eric Yeung, Catherine Paterson
Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?
Erin L. Symonds, Billie Bonevski, Richard Edwards, Nathan J. Harrison, Sana Ishaque, Nicole M. Rankin, Sibel Saya, Renee J. Smith, Carolyn Ee
An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres
Sarah Childs, David Ma, Anthony Rodrigues, Jennifer Massey, Rasha Cosman, Venessa Chin, Laila Girgis, James Lynam, Peter Lau, Barbara Withers, Anthony M. Joshua, Ben Tran, Jayesh Desai, Simon J. Harrison, John Moore, Jia Liu
Peritoneal Tuberculosis and Chronic Myeloid Leukaemia: A Case of Hickam's Dictum
Zayn Al-Timimi, Gem Chew, Martin Browne, Christiaan Mostert
From Ambition to Action: Closing Policy, Equity and Implementation Gaps in the Australian Cancer Plan's ‘Enhanced Consumer Experience’
Carla Thamm, Elise Button, Oluwaseyifunmi A. Agbejule, Reegan Knowles, Karen van Gorp, Mark B. Pinkham, Meinir Krishnasamy, Alexandra L. McCarthy, Raymond J. Chan